tiprankstipranks
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market
LXEO
Lexeo Therapeutics, Inc.
RESEARCH TOOLSreports

Lexeo Therapeutics, Inc. (LXEO) Financial Statements

Compare
288 Followers

Lexeo Therapeutics, Inc. Financial Overview

Lexeo Therapeutics, Inc.'s market cap is currently $398.51M. The company's EPS TTM is $; its P/E ratio is -4.99; Lexeo Therapeutics, Inc. is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 654.00K$ 1.66M$ 518.48K
Gross Profit$ 0.00$ 0.00$ 654.00K$ 1.66M$ 518.48K
Operating Income$ -105.77M$ -68.51M$ -60.51M$ -50.64M$ -4.59M
EBITDA$ -96.19M$ -64.35M$ -58.04M$ -50.61M$ -4.59M
Net Income$ -98.33M$ -66.39M$ -59.28M$ -50.62M$ -5.15M
Balance Sheet
Cash & Short-Term Investments$ 121.52M$ 121.47M$ 77.33M$ 135.86M$ 29.37M
Total Assets$ 146.94M$ 139.81M$ 97.08M$ 136.86M$ 29.41M
Total Debt$ 9.92M$ 11.64M$ 13.48M$ 0.00$ 0.00
Net Debt$ -25.09M$ -109.83M$ -63.85M$ -135.86M$ -29.37M
Total Liabilities$ 30.10M$ 26.27M$ 210.03M$ 192.46M$ 34.95M
Stockholders' Equity$ 116.84M$ 113.53M$ -112.95M$ -55.60M$ -5.54M
Cash Flow
Free Cash Flow$ -81.63M$ -59.66M$ -55.46M$ -44.37M$ -3.13M
Operating Cash Flow$ -81.15M$ -59.50M$ -54.56M$ -44.18M$ -3.13M
Investing Cash Flow$ -94.08M$ -165.00K$ -901.00K$ -188.00K$ 0.00
Financing Cash Flow$ 88.78M$ 103.79M$ 189.00K$ 150.86M$ 32.38M
Currency in USD

Lexeo Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Lexeo Therapeutics, Inc. Debt to Assets

Balance Sheet >

Lexeo Therapeutics, Inc. Cash Flow

Cash Flow >

Lexeo Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >